These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10402627)

  • 1. Treatment compliance in first-episode schizophrenia.
    Novak-Grubic V; Tavcar R
    Psychiatr Serv; 1999 Jul; 50(7):970-1. PubMed ID: 10402627
    [No Abstract]   [Full Text] [Related]  

  • 2. [To increase compliance-knowledge. Only every second schizophrenia patient remains faithful to the therapy].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():108. PubMed ID: 14579500
    [No Abstract]   [Full Text] [Related]  

  • 3. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to evaluate the quality of observations].
    Benoit M; Pon J; Zimmermann MA
    Encephale; 2009 Jan; Suppl 3():S87-90. PubMed ID: 19268184
    [No Abstract]   [Full Text] [Related]  

  • 4. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to make the decision to resort to an APAP)].
    Chéreau I; Gorwood P; Mouchabac S
    Encephale; 2009 Jan; Suppl 3():S97-100. PubMed ID: 19268186
    [No Abstract]   [Full Text] [Related]  

  • 5. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Current status of recommendations for treatment with an APAP].
    Buis C; Gourion D; Vaiva G
    Encephale; 2009 Jan; Suppl 3():S91-5. PubMed ID: 19268185
    [No Abstract]   [Full Text] [Related]  

  • 6. [Longterm therapy of schizophrenia].
    Pajonk FG; Wobrock T; Falkai P
    Fortschr Neurol Psychiatr; 2005 Mar; 73(3):161-74; quiz 175-7. PubMed ID: 15747226
    [No Abstract]   [Full Text] [Related]  

  • 7. Problems of compliance in the outpatient treatment of schizophrenia.
    Kane JM
    J Clin Psychiatry; 1983 Jun; 44(6 Pt 2):3-6. PubMed ID: 6133854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Depot antipsychotics in the year 2011].
    Knegtering H; Oolders H; Ruijsink MA; van der Moolen AE
    Tijdschr Psychiatr; 2011; 53(2):95-105. PubMed ID: 21319066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trial that pays patients to take antipsychotic drugs comes under attack.
    Eaton L
    BMJ; 2009 Oct; 339():b4202. PubMed ID: 19822620
    [No Abstract]   [Full Text] [Related]  

  • 11. [Maintenance pharmacotherapy of schizophrenia: remission and the effectiveness of long-acting risperidone therapy].
    Sárosi A
    Neuropsychopharmacol Hung; 2006 Dec; 8(4):179-87. PubMed ID: 17211053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for improving compliance in treatment of schizophrenia by using a long-acting formulation of an antipsychotic: clinical studies.
    Kane JM
    J Clin Psychiatry; 2003; 64 Suppl 16():34-40. PubMed ID: 14680417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-acting risperidone and oral antipsychotics in unstable schizophrenia.
    Rosenheck RA; Krystal JH; Lew R; Barnett PG; Fiore L; Valley D; Thwin SS; Vertrees JE; Liang MH;
    N Engl J Med; 2011 Mar; 364(9):842-51. PubMed ID: 21366475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raising the bar for treatment expectations in schizophrenia: achieving remission as a routine goal of antipsychotic pharmacotherapy.
    Nasrallah HA; Dursun SM
    J Psychopharmacol; 2006 Nov; 20(6 Suppl):3-5. PubMed ID: 17046983
    [No Abstract]   [Full Text] [Related]  

  • 15. Antipsychotic long-acting injections: mind the gap.
    Patel MX; Taylor M; David AS
    Br J Psychiatry Suppl; 2009 Nov; 52():S1-4. PubMed ID: 19880911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment compliance of outpatients with schizophrenia: patient's attitudes, demographic, clinical and therapeutic variables.
    Stanković Z; Britvić D; Vuković O; Ille T
    Psychiatr Danub; 2008 Mar; 20(1):42-52. PubMed ID: 18376330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial of long-acting injectable risperidone vs continuation on oral atypical antipsychotics for first-episode schizophrenia patients: initial adherence outcome.
    Weiden PJ; Schooler NR; Weedon JC; Elmouchtari A; Sunakawa A; Goldfinger SM
    J Clin Psychiatry; 2009 Oct; 70(10):1397-406. PubMed ID: 19906343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community treatment orders and antipsychotic long-acting injections.
    Lambert TJ; Singh BS; Patel MX
    Br J Psychiatry Suppl; 2009 Nov; 52():S57-62. PubMed ID: 19880919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Letter to the Editor: Whether Lack of Correlation Between Dose of Antipsychotics and Effect Is Truly Nonexistent?].
    Petrovic A; Jankovic S
    Turk Psikiyatri Derg; 2019; 30(1):71-72. PubMed ID: 31170310
    [No Abstract]   [Full Text] [Related]  

  • 20. What works in schizophrenia: depot preparations may improve outcomes.
    Haddad PM; Niaz O
    BMJ; 2006 Aug; 333(7563):353. PubMed ID: 16902223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.